Screening for undiagnosed atrial fibrillation

References

• Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation. 2014;129:837–847.
   Web of Science ®Google Scholar
• Lloyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation: the framingham heart study. Circulation. 2004;110:1042–1046.
   PubMed Web of Science ®Google Scholar
• Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (atria) study. JAMA. 2001;285:2370–2375.
   PubMed Web of Science ®Google Scholar
• Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in olmsted county, minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114:119–125.
   PubMed Web of Science ®Google Scholar
• Ball J, Carrington MJ, McMurray JJ, et al. Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. Int J Cardiol. 2013;167:1807–1824.
   PubMed Web of Science ®Google Scholar
• Ringborg A, Nieuwlaat R, Lindgren P, et al. Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation. Europace. 2008;10:403–411.
   PubMed Web of Science ®Google Scholar
• Coyne KS, Paramore C, Grandy S, et al. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research. 2006;9:348–356.
   PubMed Web of Science ®Google Scholar
• Lubitz SA, Moser C, Sullivan L, et al. Atrial fibrillation patterns and risks of subsequent stroke, heart failure, or death in the community. J Am Heart Assoc. 2013;2:e000126.
   PubMed Web of Science ®Google Scholar
• Bjorck S, Palaszewski B, Friberg L, et al. Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study. Stroke. 2013;44:3103–3108.
   PubMed Web of Science ®Google Scholar
• Marini C, De Santis F, Sacco S, et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke. 2005;36:1115–1119.
   PubMed Web of Science ®Google Scholar
• Wolf PA, Mitchell JB, Baker CS, et al. Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med. 1998;158:229–234.
   PubMed Web of Science ®Google Scholar
• Hylek EM, Go AS, Chang Y, et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med. 2003;349:1019–1026.
   PubMed Web of Science ®Google Scholar
• Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857–867.
   PubMed Web of Science ®Google Scholar
• Dentali F, Riva N, Crowther M, et al. Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature. Circulation. 2012;126:2381–2391.
   PubMed Web of Science ®Google Scholar
• Lin HJ, Wolf PA, Benjamin EJ, et al. Newly diagnosed atrial fibrillation and acute stroke. The Framingham Study. Stroke. 1995;26:1527–1530.
   PubMed Web of Science ®Google Scholar
• Wolf PA, Kannel WB, McGee DL, et al. Duration of atrial fibrillation and imminence of stroke: the Framingham study. Stroke. 1983;14:664–667.
   PubMed Web of Science ®Google Scholar
• Hobbs FD, Fitzmaurice DA, Mant J, et al. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE Study. Health Technol Assess. 2005;9:iii-iv,ix-x, 1–74.
   PubMed Web of Science ®Google Scholar
• Morgan S, Mant D. Randomised trial of two approaches to screening for atrial fibrillation in UK general practice. Br J Gen Pract. 2002;52:373–4, 7–80.
   Web of Science ®Google Scholar
• Somerville S, Somerville J, Croft P, et al. Atrial fibrillation: a comparison of methods to identify cases in general practice. Br J Gen Pract. 2000;50:727–729.
   PubMed Web of Science ®Google Scholar
• Kearley K, Selwood M, Van Den Bruel A, et al. Triage tests for identifying atrial fibrillation in primary care: a diagnostic accuracy study comparing single-lead ECG and modified BP monitors. BMJ Open. 2014;4:e004565.
   PubMed Web of Science ®Google Scholar
• Lowres N, Neubeck L, Salkeld G, et al. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF Study. Thromb Haemost. 2014;111:1167–1176.
   PubMed Web of Science ®Google Scholar
• Sudlow M, Rodgers H, Kenny RA, et al. Identification of patients with atrial fibrillation in general practice: a study of screening methods. BMJ. 1998;317:327–328.
   PubMed Web of Science ®Google Scholar
• Taggar JS, Coleman T, Lewis S, et al. Accuracy of methods for detecting an irregular pulse and suspected atrial fibrillation: a systematic review and meta-analysis. Eur J Prev Cardiol. 2016;23:1330–1338.
   PubMed Web of Science ®Google Scholar
• Marazzi G, Iellamo F, Volterrani M, et al. Comparison of microlife bp a200 plus and omron m6 blood pressure monitors to detect atrial fibrillation in hypertensive patients. Adv Ther. 2012;29:64–70.
   PubMed Web of Science ®Google Scholar
• Stergiou GS, Karpettas N, Protogerou A, et al. Diagnostic accuracy of a home blood pressure monitor to detect atrial fibrillation. J Hum Hypertens. 2009;23:654–658.
   PubMed Web of Science ®Google Scholar
• Wiesel J, Wiesel D, Suri R, et al. The use of a modified sphygmomanometer to detect atrial fibrillation in outpatients. Pacing Clin Electrophysiol. 2004;27:639–643.
   PubMed Web of Science ®Google Scholar
• Wiesel J, Fitzig L, Herschman Y, et al. Detection of atrial fibrillation using a modified microlife blood pressure monitor. Am J Hypertens. 2009;22:848–852.
   PubMed Web of Science ®Google Scholar
• Wiesel J, Abraham S, Messineo FC. Screening for asymptomatic atrial fibrillation while monitoring the blood pressure at home: trial of regular versus irregular pulse for prevention of stroke (TRIPPS 2.0). Am J Cardiol. 2013;111:1598–1601.
   PubMed Web of Science ®Google Scholar
• Wiesel J, Arbesfeld B, Schechter D. Comparison of the Microlife blood pressure monitor with the Omron blood pressure monitor for detecting atrial fibrillation. Am J Cardiol. 2014;114:1046–1048.
   PubMed Web of Science ®Google Scholar
• Doliwa PS, Frykman V, Rosenqvist M. Short-term ecg for out of hospital detection of silent atrial fibrillation episodes. Scandinavian Cardiovascular Journal. 2009;43:163-168. DOI: 10.1080/14017430802593435
   PubMed Web of Science ®Google Scholar
• Kaleschke G, Hoffmann B, Drewitz I, et al. Prospective, multicentre validation of a simple, patient-operated electrocardiographic system for the detection of arrhythmias and electrocardiographic changes. Europace. 2009;11:1362-1368.
   PubMed Web of Science ®Google Scholar
• Renier W, Geelen M, Steverlynck L, et al. Can the heartscan be used for the diagnosis and monitoring of emergencies in general practice. Acta Cardiol. 2012;67:525-531.
   PubMed Web of Science ®Google Scholar
• Vaes B, Stalpaert S, Tavernier K, et al. The diagnostic accuracy of the mydiagnostick to detect atrial fibrillation in primary care. Bmc Fam Pract. 2014;15:113.
   PubMed Web of Science ®Google Scholar
• Tielman RG, Plantinga Y, Rinkes D, et al. Validation and clinical use of a novel diagnostic device for screening atrial fibrillation. Europace. 2014;16:1291-5.
   PubMed Web of Science ®Google Scholar
• Bourdillon PJ, Kilpatrick D. Clinicians. The Mount Sinai Program and The Veterans' Administration Program Evaluated against Clinico-pathological Data Derived Independently Of The Electrogram. Eur J Cardiol. 1978;8:395-412.
   Google Scholar
• Caldwell JC, Borbas Z, Donald A, et al. Simplified electrocardiogram sampling maintains high diagnostic capability for atrial fibrillation: implicationsfor opportunistic atrial fibrillation screening in primary care. Europace. 2012;14:191-6.
   PubMed Web of Science ®Google Scholar
• Gregg RE, Zhou SH, Lindauer JM, et al. Where do derived precordial leads fail?. J Electrocardiol. 2008;41:546-52.
   PubMed Web of Science ®Google Scholar
• Lewis M, Parker D, Weston C, et al. Screening for atrial fibrillation: sensitivity and specificity of a new methodology. Br J Gen Pract. 2011;61:38–39.
   PubMed Web of Science ®Google Scholar
• Mc MD, Chong JW, Soni A, et al. PULSE-SMART: pulse-based arrhythmia discrimination using a novel smartphone application. J Cardiovasc Electrophysiol. 2016;27:51–57.
   PubMed Web of Science ®Google Scholar
• Chan PH, Wong CK, Poh YC, et al. Diagnostic performance of a smartphone-based photoplethysmographic application for atrial fibrillation screening in a primary care setting. J Am Heart Assoc. 2016;5(7). pii: e003428. doi:10.1161/JAHA.116.003428.
   Web of Science ®Google Scholar
• Svennberg E, Stridh M, Engdahl J, et al. Safe automatic one-lead electrocardiogram analysis in screening for atrial fibrillation. Europace. 2017;19:1449–1453.
   PubMed Web of Science ®Google Scholar
• Lau JK, Lowres N, Neubeck L, et al. iPhone ECG application for community screening to detect silent atrial fibrillation: a novel technology to prevent stroke. Int J Cardiol. 2013;165:193–194.
   PubMed Web of Science ®Google Scholar
• Haberman ZC, Jahn RT, Bose R, et al. Wireless smartphone ecg enables large-scale screening in diverse populations. J Cardiovasc Electrophysiol. 2015;26:520–526.
   PubMed Web of Science ®Google Scholar
• McManus D, Chong JW, Soni A, et al. Pulse_smart:pulse-based arrhythmia discrimination using a novel smartphone application. J Cardiovasc Electrophysiol. 2016;27:51-7.
   PubMed Web of Science ®Google Scholar
• Rosenberg MA, Samuel M, Thosani A, et al. Use of a noninvasive continuous monitoring device in the management of atrial fibrillation: a pilot study. Pacing Clin Electrophysiol. 2013;36:328–333.
   PubMed Web of Science ®Google Scholar
• Barrett PM, Komatireddy R, Haaser S, et al. Comparison of 24-hour Holter monitoring with 14-day novel adhesive patch electrocardiographic monitoring. Am J Med. 2014;127(95):e11–7.
   Google Scholar
• Turakhia MP, Ullal AJ, Hoang DD, et al. Feasibility of extended ambulatory electrocardiogram monitoring to identify silent atrial fibrillation in high-risk patients: the screening study for undiagnosed atrial fibrillation (study-af). Clin Cardiol. 2015;116:733–739.
   PubMed Web of Science ®Google Scholar
• Tayal AH, Tian M, Kelly KM, et al. Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke. Neurology. 2008;71:1696–1701.
   PubMed Web of Science ®Google Scholar
• Miller DJ, Khan MA, Schultz LR, et al. Outpatient cardiac telemetry detects a high rate of atrial fibrillation in cryptogenic stroke. J Neurol Sci. 2013;324:57–61.
   PubMed Web of Science ®Google Scholar
• Couderc JP, Kyal S, Mestha LK, et al. Detection of atrial fibrillation using contactless facial video monitoring. Heart Rhythm. 2015;12:195–201.
   PubMed Web of Science ®Google Scholar
• Graz study on the risk of atrial fibrillation (GRAF),NCT01461434, Available from: clinicaltrials.gov
   Google Scholar
• Healey JS, Alings M, Ha A, et al. Subclinical atrial fibrillation in older patients. Circulation. 2017;136:1276–1283.
   PubMed Web of Science ®Google Scholar
• Nasir JM, Pomeroy W, Marler A, et al. Predicting determinants of atrial fibrillation or flutter for therapy elucidation in patients at risk for thromboembolic events (predate af) study. Heart Rhythm. 2017;14:955–961.
   PubMed Web of Science ®Google Scholar
• Reiffel JA, Verma A, Kowey PR, et al. Incidence of previously undiagnosed atrial fibrillation using insertable cardiac monitors in a high-risk population: the reveal af study. JAMA Cardiol. 2017;2:1120–1127.
   PubMed Web of Science ®Google Scholar
• Fitzmaurice DA, Hobbs FD, Jowett S, et al. Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial. BMJ. 2007;335(383).
   Google Scholar
• Benito L, Coll-Vinent B, Gomez E, et al. EARLY: a pilot study on early diagnosis of atrial fibrillation in a primary healthcare centre. Europace. 2015;17:1688–1693.
   PubMed Web of Science ®Google Scholar
• Camm AJ, Lip GY, De Caterina R, et al. focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the Special Contribution of the European Heart Rhythm Association. Eur Heart J. 2012. 2012;33:2719–2747.
   Google Scholar
• Engdahl J, Andersson L, Mirskaya M, et al. Stepwise screening of atrial fibrillation in a 75-year-old population: implications for stroke prevention. Circulation. 2013;127:930–937.
   PubMed Web of Science ®Google Scholar
• Svennberg E, Engdahl J, Al-Khalili F, et al. Mass screening for untreated atrial fibrillation: the strokestop study. Circulation. 2015;131:2176–2184.
   PubMed Web of Science ®Google Scholar
• Ntaios G, Manios E, Synetou M, et al. Prevalence of atrial fibrillation in greece: the arcadia rural study on atrial fibrillation. Acta Cardiologica. 2012;67:65–69.
   PubMed Web of Science ®Google Scholar
• Proietti M, Mairesse GH, Goethals P, et al. A population screening programme for atrial fibrillation: a report from the belgian heart rhythm week screening programme. Europace 2016.
   Google Scholar
• Yap KB, Ng TP, Ong HY. Low prevalence of atrial fibrillation in community-dwelling Chinese aged 55 years or older in Singapore: a population-based study. J Electrocardiol. 2008;41:94–98.
   PubMed Web of Science ®Google Scholar
• Lowres N, Neubeck L, Redfern J, et al. Screening to identify unknown atrial fibrillation. A Systematic Review. Thromb Haemost. 2013;110:213–222.
   PubMed Web of Science ®Google Scholar
• Rhys GC, Azhar MF, Foster A. Screening for atrial fibrillation in patients aged 65 years or over attending annual flu vaccination clinics at a single general practice. Qual Prim Care. 2013;21:131–140.
   PubMedGoogle Scholar
• Kaasenbrood F, Hollander M, Rutten FH, et al. Yield of screening for atrial fibrillation in primary care with a hand-held, single-lead electrocardiogram device during influenza vaccination. Europace. 2016;18:1514–1520.
   PubMed Web of Science ®Google Scholar
• Sandhu RKDL, Deif B, Barake W, et al. High prevalence of modifiable stroke risk factors identified in a pharmacy-based screening programme. 2016.
   Google Scholar
• Freedman B, Camm J, Calkins H, et al. Screening for atrial fibrillation: a report of the AF-SCREEN International Collaboration. Circulation. 2017;135:1851–1867.
   PubMed Web of Science ®Google Scholar
• Mairesse GH, Moran P, Van Gelder IC, et al. Screening for atrial fibrillation: a european heart rhythm association (ehra) consensus document endorsed by the heart rhythm society (hrs), asia pacific heart rhythm society (aphrs), and sociedad latinoamericana de estimulacion cardiaca y electrofisiologia (solaece). Europace. 2017;19:1589–1623.
   PubMed Web of Science ®Google Scholar
• Moran PS, Flattery MJ, Teljeur C, et al. Effectiveness of systematic screening for the detection of atrial fibrillation. Cochrane Database Syst Rev. 2013;CD009586.
   PubMed Web of Science ®Google Scholar
• Aronsson M, Svennberg E, Rosenqvist M, et al. Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording. Europace. 2015;17:1023–1029.
   PubMed Web of Science ®Google Scholar
• Clua-Espuny JL, Lechuga-Duran I, Bosch-Princep R, et al. Prevalence of undiagnosed atrial fibrillation and of that not being treated with anticoagulant drugs: the AFABE study. Rev Esp Cardiol (Engl Ed). 2013;66:545–552.
   PubMed Web of Science ®Google Scholar
• Levin LA, Husberg M, Sobocinski PD, et al. A cost-effectiveness analysis of screening for silent atrial fibrillation after ischaemic stroke. Europace. 2015;17:207–214.
   PubMed Web of Science ®Google Scholar
• Tarride JE, Dolovich L, Blackhouse G, et al. Screening for atrial fibrillation in Canadian pharmacies: an economic evaluation. CMAJ Open. 2017;5:E653–E61.
   PubMedGoogle Scholar
• Turakhia MP, Shafrin J, Bognar K, et al. Economic burden of undiagnosed nonvalvular atrial fibrillation in the united states. Am J Cardiol. 2015;116:733–739.
   PubMed Web of Science ®Google Scholar
• Kirchhof P, Benussi S, Kotecha D, et al. Esc guidelines for the management of atrial fibrillation developed in collaboration with eacts: the task force for the management of atrial fibrillation of the european society of cardiology (esc)developed with the special contribution of the european heart rhythm association (ehra) of the escendorsed by the european stroke organisation (eso). In: Europace. Eur Heart J. 2016;37:2893-962.
   Google Scholar
• Wilson JM, Jungner YG. [Principles and practice of mass screening for disease]. Boletin De La Oficina Sanitaria Panamericana Pan American Sanitary Bureau. 1968;65:281–393.
   PubMedGoogle Scholar
• Sterne JA, Bodalia PN, Bryden PA, et al. Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis. Health Technol Assess. 2017;21:1–386.
   Web of Science ®Google Scholar
• Lowres N, Krass I, Neubeck L, et al. Atrial fibrillation screening in pharmacies using an iPhone ECG: a qualitative review of implementation. Int J Clin Pharm. 2015;37:1111–1120.
   PubMed Web of Science ®Google Scholar
• Orchard J, Freedman SB, Lowres N, et al. iPhone ECG screening by practice nurses and receptionists for atrial fibrillation in general practice: the GP-SEARCH qualitative pilot study. Aust Fam Physician. 2014;43:315–319.
   PubMed Web of Science ®Google Scholar
• Gladstone DJ, Spring M, Dorian P, et al. Atrial fibrillation in patients with cryptogenic stroke. N Engl Med. 2014;370:2467–2477.
   PubMed Web of Science ®Google Scholar
• Gladstone DJ, Bui E, Fang J, et al. Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated. Stroke. 2009;40:235–240.
   PubMed Web of Science ®Google Scholar
• Saposnik G, Gladstone D, Raptis R, et al. Atrial fibrillation in ischemic stroke: predicting response to thrombolysis and clinical outcomes. Stroke. 2013;44:99–104.
   PubMed Web of Science ®Google Scholar
• January CT, Wann LS, Alpert JS, et al. AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the heart rhythm society. J Am Coll Cardiol. 2014. 2014;64:e1–76.
   PubMed Web of Science ®Google Scholar
• Macle L, Cairns J, Leblanc K, et al. Focused update of the canadian cardiovascular society guidelines for the management of atrial fibrillation. Can J Cardiol. 2016. 2016;32:1170–1185.
   Google Scholar